The marketing of medicinal products whose labelling and package leaflets comply with this Directive should not be prohibited or impeded on grounds connected with the labelling or package leaflet.
Recital 41, Directive (EU) 2001/83
In forcecited 1×
Judgment of the Court (Fifth Chamber) of 17 November 2022. Merck Sharp & Dohme BV and Others v Abacus Medicine A/S and Others.Decision
Recitals 2 to 5, 14, 40 and 41 of Directive 2001/83 state: The essential aim of any rules governing the production, distribution and use of medicinal products must be to safeguard public health. However, this objective must be attained by …
17 Nov 2022 · 62020CJ0224